Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05415670Completed

Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)

Role: collaborator

NCT07005999Active Not Recruiting

Interventional Ablation for Early-stage Lung Cancer

Role: collaborator

NCT06331923Not ApplicableRecruiting

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes

Role: collaborator

NCT05059873Phase 4Terminated

Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels

Role: collaborator

NCT06480214Recruiting

Research on Key Technology Development and Clinical Application of Small Interactive Spinal Endoscopic Surgery Robot

Role: collaborator

NCT04656964Not ApplicableCompleted

Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy

Role: collaborator

NCT05841082Unknown

Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry

Role: collaborator

NCT04597346Unknown

Evaluate the Diagnostic Value of BTPNA for PPL: a Real-world Study

Role: collaborator

NCT05209607Phase 4Unknown

Social Media-based Bundle Care of AECOPD Patients.

Role: collaborator

All 9 trials loaded